Eur Respir J 2003; 21:633-636
Copyright ©ERS Journals Ltd 2003
Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma
D. Sim1,
A. Griffiths1,
D. Armstrong1,
C. Clarke2,
C. Rodda2 and
N. Freezer1,3
Depts of 1 Respiratory and Sleep Medicine and 2 Paediatric Endocrinology, Monash Medical Centre and 3 Centre for Heart and Chest Research, Monash University, Melbourne, Australia
CORRESPONDENCE: N. Freezer, Respiratory and Sleep Medicine, Monash Medical Centre, Melbourne, Australia. Fax: 61 395946415. E-mail: n.freezer@southernhealth.org.au
Keywords: adrenal suppression, asthma, children, flixotide
Received: January 3, 2002
Accepted May 25, 2002
This cross-sectional study was designed to examine the prevalence of adrenocortical suppression in children with asthma treated with high-dose inhaled fluticasone propionate (FP).
Children and adolescents (n=50) with asthma, treated with inhaled FP at a dose of 1,000 mg a day for 6 months, were enrolled. Early morning serum cortisol was performed. Subjects with a serum cortisol of <400 nmol·L1 had a tetracosactrin stimulation test.
Fifty subjects of mean age 13.1 yrs were treated with a mean dose of 924.7 µg·m2·day1 FP for a mean duration of 2 yrs. Of the 50 subjects, 36 (72%) had serum cortisol levels of <400 nmol·L1 and underwent tetracosactrin stimulation test. Of these, 6 (17%) demonstrated a less than two-fold increase in serum cortisol from baseline and peak cortisol level of 550 nmol·L1 at 30 or 60 min poststimulation. There was a significant negative correlation between the dose of FP·m2 and stimulated peak cortisol level.
Biochemical evidence of adrenocortical insufficiency was demonstrated in 12% of the subjects, indicating that high-dose fluticasone propionate use may be associated with dose-dependent adrenocortical suppression.
This article has been cited by other articles:

|
 |

|
 |
 
S Turner, M Thomas, J von Ziegenweidt, and D Price
Prescribing trends in asthma: a longitudinal observational study
Arch. Dis. Child.,
January 1, 2009;
94(1):
16 - 22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Paton, E Jardine, E McNeill, S Beaton, P Galloway, D Young, and M Donaldson
Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone
Arch. Dis. Child.,
October 1, 2006;
91(10):
808 - 813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D R Woods, C S Arun, P A Corris, and P Perros
Cushing's syndrome without excess cortisol.
BMJ,
February 25, 2006;
332(7539):
469 - 470.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. N. Priftis, A. Papadimitriou, E. Gatsopoulou, P. K. Yiallouros, A. Fretzayas, and P. Nicolaidou
The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children
Eur. Respir. J.,
February 1, 2006;
27(2):
316 - 320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Saglani, A. G. Nicholson, M. Scallan, I. Balfour-Lynn, M. Rosenthal, D. N. Payne, and A. Bush
Investigation of young children with severe recurrent wheeze: any clinical benefit?
Eur. Respir. J.,
January 1, 2006;
27(1):
29 - 35.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Tattersfield, T. W. Harrison, R. B. Hubbard, and K. Mortimer
Safety of Inhaled Corticosteroids
Proceedings of the ATS,
November 1, 2004;
1(3):
171 - 175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Mahachoklertwattana, K Sudkronrayudh, C Direkwattanachai, L Choubtum, and C Okascharoen
Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate
Arch. Dis. Child.,
November 1, 2004;
89(11):
1055 - 1058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.J. Visser, E. van der Veer, D.S. Postma, L.R. Arends, T.W. de Vries, P.L.P. Brand, and E.J. Duiverman
Side-effects of fluticasone in asthmatic children: no effects after dose reduction
Eur. Respir. J.,
September 1, 2004;
24(3):
420 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mohn, M. Verini, R. Mele, C. De Leonardis, and F. Chiarelli
Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma
Eur. Respir. J.,
February 1, 2004;
23(2):
354 - 355.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the European Respiratory Society.
|